Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now full pipeline small index

Dental Pain: full-pipeline trial registry

3 of 7 indexed Dental Pain trials are currently recruiting.

Corpus placement: #2,497 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

7 US clinical trials · 3 currently recruiting · #2,497 of 28,707 conditions by registered trial count

Dental Pain: 7 US clinical trials tracked, 3 recruiting.

Dental Pain is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Donald Nixdorf, running 1 of these trials.

Enrollment posture brief

Registry condition dental-pain

OPEN 3 | RECR 43% | LATE 2 | EARLY 2 | RANK #2497 | SPON 1

Volume-matched condition peers

Nearest open-share peer: Adrenoleukodystrophy (43% recruiting · 7 trials)

ACL Tear71.4%ACL57.1%Dental Pain (this)43%Acute Myelogenous Leukemia42.9%Acne Scars28.6%
Open-enrollment share among volume-matched conditions near Dental Pain

Dental Pain lists 3 open slots (43% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Dental Pain on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Dental Pain is recruiting below its size-band peers.

    3 of 7 indexed trials (42.9%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Dental Pain trials is spread across many organizations.

    Donald Nixdorf accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.

  3. Typical Dental Pain enrolment sits around 200 participants.

    Median target enrolment is 200 among the 7 trials that report a genuine target (sentinel values excluded). 1 of those (14.3%) plan for fewer than 100 participants.

  4. Dental Pain research is mostly interventional.

    5 interventional and 2 observational studies make up this index (71.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 22Phase 32

Phase Distribution

PhaseTrial count
Phase 2 2
Phase 3 2

Top Sponsors

Donald Nixdorf 1 trials
Xenon Pharmaceuticals 1 trials
Pacira Pharmaceuticals 1 trials
Pfizer 1 trials
University of Maryland, Baltimore 1 trials
GlaxoSmithKline 1 trials
University of California, San Francisco 1 trials

Named interventions

Most-linked intervention names on Dental Pain records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Bupivacaine liposome Drug
1 trials
XPF-001 Drug
1 trials
Celecoxib, COX-2 inhibitor; oral Drug
1 trials
GW406381 Drug
1 trials
Placebo; oral Drug
1 trials
ARRY-371797, p38 inhibitor; oral Drug
1 trials
Local Anesthesia Drug
1 trials
Topical Benzocaine Drug
1 trials

US sites by state

Facility locations filed on Dental Pain trials. A trial with sites in several states counts in each.

Utah 3 trials
Texas 2 trials
Minnesota 1 trials
Maryland 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Dental Pain page

7 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Dental Pain condition card totals 7 registered trials; most-linked intervention Bupivacaine liposome; top US site state Utah. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.